Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
4
×
investing
4
×
life sciences
national blog main
national top stories
sanofi
4
×
cancer
clinical trials
roche
san francisco blog main
san francisco top stories
startups
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
johnson & johnson
medicaid
national
new york blog main
new york top stories
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abiraterone
What
drug
cancer
medicines
potential
roundup
targets
address
adds
ago
ahead
allosteric
alzheimer’s
ambien
american
annual
asco
attendees
attention
bio
biotech
camp’s
cash
chicago
city
clinic
clinical
combinations
community’s
companies
days
despite
different
disease
elusive
expanding
fail
family
focus
gene
hardest
Language
unset
Current search:
sanofi
×
deals
×
investing
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
